Free Trial
NASDAQ:CELU

Celularity (CELU) Stock Price, News & Analysis

Celularity logo
$2.12 +0.23 (+12.17%)
Closing price 07/9/2025 04:00 PM Eastern
Extended Trading
$2.13 +0.01 (+0.47%)
As of 07/9/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Celularity Stock (NASDAQ:CELU)

Key Stats

Today's Range
$1.87
$2.15
50-Day Range
$1.52
$2.49
52-Week Range
$1.00
$5.22
Volume
127,729 shs
Average Volume
339,145 shs
Market Capitalization
$50.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Celularity Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
4th Percentile Overall Score

CELU MarketRank™: 

Celularity scored higher than 4% of companies evaluated by MarketBeat, and ranked 913th out of 920 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Celularity.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Celularity is -0.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Celularity is -0.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Celularity has a P/B Ratio of 5.73. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    10.43% of the float of Celularity has been sold short.
  • Short Interest Ratio / Days to Cover

    Celularity has a short interest ratio ("days to cover") of 19, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Celularity has recently decreased by 2.70%, indicating that investor sentiment is improving.
  • Dividend Yield

    Celularity does not currently pay a dividend.

  • Dividend Growth

    Celularity does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    10.43% of the float of Celularity has been sold short.
  • Short Interest Ratio / Days to Cover

    Celularity has a short interest ratio ("days to cover") of 19, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Celularity has recently decreased by 2.70%, indicating that investor sentiment is improving.
  • News Sentiment

    Celularity has a news sentiment score of 0.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Celularity this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Celularity insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    22.10% of the stock of Celularity is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 19.02% of the stock of Celularity is held by institutions.

  • Read more about Celularity's insider trading history.
Receive CELU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Celularity and its competitors with MarketBeat's FREE daily newsletter.

CELU Stock News Headlines

Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Celularity Terminates CFO David Beers
See More Headlines

CELU Stock Analysis - Frequently Asked Questions

Celularity's stock was trading at $2.08 on January 1st, 2025. Since then, CELU shares have increased by 1.9% and is now trading at $2.12.

Celularity, Inc. (NASDAQ:CELU) released its quarterly earnings data on Thursday, May, 8th. The company reported ($0.59) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($1.50) by $0.91. The company earned $18.13 million during the quarter, compared to analysts' expectations of $5.20 million. Celularity had a negative trailing twelve-month return on equity of 271.88% and a negative net margin of 106.77%.

Shares of Celularity reverse split on Thursday, February 29th 2024.The 1-10 reverse split was announced on Thursday, February 29th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, February 29th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of CELU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Celularity investors own include NVIDIA (NVDA), Meta Platforms (META), Lovesac (LOVE), MannKind (MNKD), PayPal (PYPL), Tesla (TSLA) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
5/08/2025
Today
7/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CELU
CIK
1752828
Fax
N/A
Employees
220
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$57.89 million
Net Margins
-106.77%
Pretax Margin
-106.77%

Debt

Sales & Book Value

Annual Sales
$54.22 million
Price / Cash Flow
N/A
Book Value
$0.37 per share
Price / Book
5.73

Miscellaneous

Free Float
18,656,000
Market Cap
$50.77 million
Optionable
Optionable
Beta
0.74
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:CELU) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners